Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

XERIS PHARMACEUTICALS INC (XERS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20Mar-31-20Mar-05-20
   10-Q8-K10-K10-Q10-Q8-K10-Q8-K
Net sales  8.88.17.19.42.02.01.71.7
            Net sales growth  340.0%373.6%333.6%     
Grant and other income  0.10.10.10.00.00.00.10.1
Cost of goods sold  3.4 3.42.81.3 1.8 
    Gross profit  5.56.43.86.60.70.70.00.0
            Gross margin  62.8%79.1%53.4%70.4%36.4%36.7%-0.1%-0.1%
   
Operating expenses:          
Research and development  5.44.05.13.95.35.36.66.6
Selling, general and administrative  25.919.118.016.517.617.621.621.6
    Total operating expenses  31.323.123.120.422.922.928.328.3
    Loss from operations  -25.8-16.7-19.3-13.7-22.2-22.2-28.3-28.3
            Operating margin  -293.0%-207.9%-274.2%-146.2%-1110.3%-1118.1%-1662.0%-1685.8%
   
Other income (expense):          
Interest and other income  0.1 2.00.20.3 0.4 
Interest expense  -1.8-1.8-4.6-2.3-2.2 -1.5 
Change in fair value of warrants  0.0 0.1-0.20.0 0.1 
    Total other income (expense)  -1.71.7-2.5-2.3-2.0-2.0-0.9-0.9
Net loss before benefit from income taxes  -27.5 -21.9-16.0-24.2 -29.2 
Benefit from income taxes    0.2 -0.1-0.1  
    Net loss  -27.5-18.4-21.9-16.0-24.1-24.1-29.2-29.2
   
Other comprehensive income (loss), net of tax:          
Unrealized gains (losses) on investments  0.0 0.0-0.10.1   
Foreign currency translation adjustments  0.0 0.00.00.0 0.0 
    Comprehensive loss  -27.5   -24.0   
   
Net loss per common share - basic and diluted  ($0.41)($0.30)($0.36)($0.35)($0.63)($0.63)($0.89)($0.89)
   
Weighted average common shares outstanding - basic and diluted  66.461.242.646.138.038.032.832.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy